贺婷, 助理教授, 硕士生导师，于2017年获中国科学院大连化学物理研究所博士学位，师从纳米界面研究专家包信和院士。同年加入深圳大学医学部生物医学工程学院从事博士后研究，出站后留校任专职副研究员，2023年转为助理教授。研究方向为响应型纳米药物在肿瘤多模协同治疗过程中的应用。近年来开发了多种肿瘤微环境响应型纳米材料，实现了磁共振/光声/荧光多模态成像指导的肿瘤化学动力学、光热、光动力等多种治疗手段的联合应用。在Angewandte Chemie、Advanced Materials、ACS Applied Materials Interfaces等国际期刊共发表27篇SCI论文，总引用超过2500次。

（1）青年科学基金项目，22107073，2022-01-01至2024-12-31，30万元，在研，主持。

（2）国家重点研发，2020YFA0908802，2020-11至2025-10，450万元，在研，参与。

（3）深圳市科技计划项目，JCYJ20200109105620482，2020-12至2023-12，200万元，在研，参与。

(1) He, Ting; Yuan, Yanyan; Jiang, Chao; Blum, Nicholas Thomas; He, Jin; Huang, Peng; Lin, Jing ; Light‐Triggered Transformable Ferrous Ion Delivery System for Photothermal Primed Chemodynamic Therapy, Angewandte Chemie International Edition, 2021, 133(11): 6112-6119.

(2) He, Ting; Jiang, Chao; He, Jin; Zhang, Yifan; He, Gang; Wu, Jiayingzi; Lin, Jing; Zhou, Xin; Huang, Peng; Manganese-Dioxide-Coating-Instructed Plasmonic Modulation of Gold Nanorods for Activatable Duplex-Imaging-Guided NIR-II Photothermal-Chemodynamic Therapy, Advanced Materials, 2021, 13(33): 2008540.

(3) He, Ting; Qin, Xialing; Jiang, Chao; Jiang, Dawei; Lei, Shan; Lin, Jing; Zhu, Weiguo; Qu, Junle; Huang, Peng; Tumor pH-Responsive Metastable-Phase Manganese Sulfide Nanotheranostics for Traceable Hydrogen Sulfide Gas Therapy Primed Chemodynamic Therapy., Theranostics, 2020, 10(6): 2453-2462.

(4) He, Ting; Xu, Han; Zhang, Yifan; Yi, Shijian; Cui, Run; Xing, Shaojun; Wei, Chaoliang; Lin, Jing; Huang, Peng; Glucose Oxidase-Instructed Traceable Self-Oxygenation/Hyperthermia Dually Enhanced Cancer Starvation Therapy, Theranostics, 2020, 10(4): 1544-1554.

(5) He, Ting; He, Jin; Younis, Muhammad Rizwan; Blum, Nicholas Thomas; Lei, Shan; Zhang, Yinling; Huang, Peng; Lin, Jing; Dual-Stimuli-Responsive Nanotheranostics for Dual-Targeting Photothermal-Enhanced Chemotherapy of Tumor, ACS Applied Materials & Interfaces, 2021, 13(19): 22204-22212.